Patient Convenience Study

Active, not recruiting

Phase N/A Results N/A

Summary of Purpose

The aim of this non-interventional study is to describe patient's perception of anticoagulant treatment when using Pradaxa® to prevent stroke and systemic embolism while suffering from atrial fibrillation (according to its approved indication in the approved dosages of 110 mg or 150 mg twice daily) in comparison to standard care using Vitamin K Antagonist (VKA).

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 10 October 2016.

1 Nov 2015 4 Nov 2015 1 Jan 2017 1 Jan 2017 1 Oct 2016 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics




Trial Design

  • Observation: Cohort
  • Perspective: Prospective
  • Sampling: Non-Probability Sample